CannTrust Holdings Inc. produces and sells medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is headquartered in Vaughan, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone647-872-2300
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$54.66 million
Profitability
Miscellaneous
Employees576
Next Earnings DateN/A
OptionableOptionable
CannTrust (TSE:TRST) Frequently Asked Questions
What is CannTrust's stock symbol?
CannTrust trades on the Toronto Stock Exchange (TSX) under the ticker symbol "TRST."
What price target have analysts set for TRST?
4 equities research analysts have issued 12-month price targets for CannTrust's shares. Their forecasts range from C$2.00 to C$13.00. On average, they expect CannTrust's stock price to reach C$7.00 in the next twelve months. This suggests a possible upside of 483.3% from the stock's current price. View Analyst Price Targets for CannTrust.
What is the consensus analysts' recommendation for CannTrust?
4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CannTrust in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CannTrust.
Has CannTrust been receiving favorable news coverage?
News coverage about TRST stock has trended negative this week, InfoTrie Sentiment reports. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. CannTrust earned a news sentiment score of -2.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for CannTrust.
Who are some of CannTrust's key competitors?
Some companies that are related to CannTrust include OrganiGram (OGI), HEXO (HEXO), Next Science (NXS), HLS Therapeutics (HLS), Supreme Cannabis (FIRE), Green Organic Dutchman (TGOD), Benchmark (BMK), ICC Labs (ICC), Shield Therapeutics (STX), Flowr (FLWR), Amryt Pharma (AMYT), Althea Group (AGH), WeedMD (WMD), Probiotec (PBP) and Auscann Group (AC8).
What other stocks do shareholders of CannTrust own?
Who are CannTrust's key executives?
CannTrust's management team includes the folowing people:
- Mr. Eric Paul, Co-Founder & Chairman (Age 78)
- Mr. Brad Rogers, Pres (Age 49)
- Mr. Ian Abramowitz, Sr. VP of Global Investments & Partnerships (Age 64)
- Mr. Peter Ralph Aceto, Chief Exec. Officer
- Mr. Greg Guyatt, Chief Financial Officer
How do I buy shares of CannTrust?
Shares of TRST and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CannTrust's stock price today?
One share of TRST stock can currently be purchased for approximately C$1.20.
How big of a company is CannTrust?
What is CannTrust's official website?
How can I contact CannTrust?
The company can be reached via phone at 647-872-2300.
MarketBeat Community Rating for CannTrust (TSE TRST)
MarketBeat's community ratings are surveys of what our community members think about CannTrust and other stocks. Vote "Outperform" if you believe TRST will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRST will underperform the S&P 500 over the long term. You may vote once every thirty days.
